{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:03:31Z","timestamp":1790039011647,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010881","name":"Suzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["SKY2023180"],"award-info":[{"award-number":["SKY2023180"]}],"id":[{"id":"10.13039\/501100010881","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010881","name":"Suzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["SKY2023041"],"award-info":[{"award-number":["SKY2023041"]}],"id":[{"id":"10.13039\/501100010881","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010881","name":"Suzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["SYW2024077"],"award-info":[{"award-number":["SYW2024077"]}],"id":[{"id":"10.13039\/501100010881","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019643","name":"State Key Laboratory of Radiation Medicine and Protection","doi-asserted-by":"publisher","award":["GZK12025062"],"award-info":[{"award-number":["GZK12025062"]}],"id":[{"id":"10.13039\/501100019643","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018556","name":"Science and Technology Program of Suzhou","doi-asserted-by":"publisher","award":["KJXW2023016"],"award-info":[{"award-number":["KJXW2023016"]}],"id":[{"id":"10.13039\/501100018556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014358","name":"Second Affiliated Hospital of Soochow University","doi-asserted-by":"publisher","award":["ND2023B06"],"award-info":[{"award-number":["ND2023B06"]}],"id":[{"id":"10.13039\/501100014358","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173596"],"award-info":[{"award-number":["82173596"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Cardiology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ajpc.2026.101785","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T23:46:03Z","timestamp":1786059963000},"page":"101785","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Circulating PCSK9 as a sex-stratified predictor in primary prevention of cardiovascular disease: Insights from a prospective cohort study in Chinese adults"],"prefix":"10.1016","volume":"30","author":[{"given":"Longhai","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyue","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianfeng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhe","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penghao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6277-662X","authenticated-orcid":false,"given":"Hao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jijun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ajpc.2026.101785_bib0001","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s11883-022-01057-z","article-title":"Expanding biology of PCSK9: roles in atherosclerosis and beyond","volume":"24","author":"Seidah","year":"2022","journal-title":"Curr Atheroscler Rep"},{"issue":"18","key":"10.1016\/j.ajpc.2026.101785_bib0002","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2026.101785_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2025.1529506","article-title":"The epidemiology and burden of atherosclerotic cardiovascular disease in China from 1990 to 2021: findings from the global burden of disease 2021","volume":"13","author":"Hou","year":"2025","journal-title":"Front Public Health"},{"issue":"22","key":"10.1016\/j.ajpc.2026.101785_bib0004","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2026.101785_bib0005","article-title":"Evolocumab in patients without a previous myocardial infarction or stroke","author":"Bohula","year":"2025","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ajpc.2026.101785_bib0006","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.3390\/ijms24031966","article-title":"PCSK9 as an atherothrombotic risk factor","volume":"24","author":"Sotler","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.ajpc.2026.101785_bib0007","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/ehjcvp\/pvz022","article-title":"PCSK9 and inflammation: a review of experimental and clinical evidence","volume":"5","author":"Momtazi-Borojeni","year":"2019","journal-title":"Euro Heart J Cardiovasc Pharmacother"},{"issue":"2","key":"10.1016\/j.ajpc.2026.101785_bib0008","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.3892\/mmr.2017.6803","article-title":"Investigation of highly expressed PCSK9 in atherosclerotic plaques and ox-LDL-induced endothelial cell apoptosis","volume":"16","author":"Li","year":"2017","journal-title":"Mol Med Rep"},{"issue":"6","key":"10.1016\/j.ajpc.2026.101785_bib0009","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/CIRCRESAHA.114.301621","article-title":"PCSK9: a key modulator of cardiovascular health","volume":"114","author":"Seidah","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpc.2026.101785_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117444","article-title":"Insight into the role of PCSK9 in glucose metabolism","volume":"547","author":"Xu","year":"2023","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ajpc.2026.101785_bib0011","doi-asserted-by":"crossref","DOI":"10.14336\/AD.2024.1713","article-title":"PCSK9 in vascular aging and age-related diseases","author":"Tan","year":"2025","journal-title":"Aging Dis"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101785_bib0012","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12933-020-01142-0","article-title":"Association of circulating PCSK9 concentration with cardiovascular metabolic markers and outcomes in stable coronary artery disease patients with or without diabetes: a prospective, observational cohort study","volume":"19","author":"Peng","year":"2020","journal-title":"Cardiovasc Diabetol"},{"issue":"13","key":"10.1016\/j.ajpc.2026.101785_bib0013","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1161\/CIRCULATIONAHA.115.018531","article-title":"Circulating Proprotein convertase Subtilisin\/Kexin type 9 (PCSK9) predicts future risk of cardiovascular events independently of established risk factors","volume":"133","author":"Leander","year":"2016","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ajpc.2026.101785_bib0014","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1177\/2047487319880985","article-title":"Plasma proprotein convertase subtilisin\/kexin type 9 concentration and recurrent cardiovascular events in patients with familial hypercholesterolemia","volume":"28","author":"Cao","year":"2021","journal-title":"Eur J Prev Cardiol"},{"issue":"3","key":"10.1016\/j.ajpc.2026.101785_bib0015","doi-asserted-by":"crossref","DOI":"10.5041\/RMMJ.10443","article-title":"Circulating proprotein convertase Subtilisin\/Kexin type 9 levels predict future cardiovascular event risks in hemodialyzed black African patients","volume":"12","author":"Kajingulu","year":"2021","journal-title":"Rambam Maimonides Med J"},{"issue":"10","key":"10.1016\/j.ajpc.2026.101785_bib0016","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1161\/ATVBAHA.115.306172","article-title":"Association of Proprotein Convertase Subtilisin\/Kexin type 9 (PCSK9) with cardiovascular risk in primary prevention","volume":"35","author":"Zhu","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"13","key":"10.1016\/j.ajpc.2026.101785_bib0017","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.3390\/jcm14134469","article-title":"PCSK9-Targeting drugs and gender: are there any differences?","volume":"14","author":"Liberati","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.ajpc.2026.101785_bib0018","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cca.2015.03.036","article-title":"Relationship between testosterone, estradiol and circulating PCSK9: cross-sectional and interventional studies in humans","volume":"446","author":"Ooi","year":"2015","journal-title":"Clin Chim Acta"},{"issue":"4","key":"10.1016\/j.ajpc.2026.101785_bib0019","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jacasi.2022.01.004","article-title":"Soluble corin predicts the risk of cardiovascular disease: a 10-year follow-up study","volume":"2","author":"Chen","year":"2022","journal-title":"JACC Asia"},{"issue":"18","key":"10.1016\/j.ajpc.2026.101785_bib0020","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.035858","article-title":"Association between genetically determined serum corin and the risk of stroke in Chinese adults: a mendelian randomization study","volume":"13","author":"Liu","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101785_bib0021","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/HJH.0000000000000065","article-title":"Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension","volume":"32","author":"Weber","year":"2014","journal-title":"J Hypertens"},{"issue":"5","key":"10.1016\/j.ajpc.2026.101785_bib0022","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA, J Am Med Assoc"},{"issue":"Suppl 1","key":"10.1016\/j.ajpc.2026.101785_bib0023","article-title":"Classification and diagnosis of diabetes: standards of medical care in diabetes-2020","volume":"43","year":"2020","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.ajpc.2026.101785_bib0024","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101785_bib0025","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s12933-023-01948-8","article-title":"Circulating PCSK9 as a prognostic biomarker of cardiovascular events in individuals with type 2 diabetes: evidence from a 16.8-year follow-up study","volume":"22","author":"Ruscica","year":"2023","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"10.1016\/j.ajpc.2026.101785_bib0026","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018263","article-title":"Patients with LDLR and PCSK9 gene variants experienced higher incidence of cardiovascular outcomes in heterozygous familial hypercholesterolemia","volume":"10","author":"Doi","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"10.1016\/j.ajpc.2026.101785_bib0027","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jacbts.2016.06.007","article-title":"Circulating PCSK9 and risk of myocardial infarction: the HUNT study in Norway","volume":"1","author":"Laugsand","year":"2016","journal-title":"JACC Basic Transl Sci"},{"issue":"6","key":"10.1016\/j.ajpc.2026.101785_bib0028","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/eurheartj\/ehv568","article-title":"Plasma proprotein convertase subtilisin\/kexin type 9 levels and the risk of first cardiovascular events","volume":"37","author":"Ridker","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2026.101785_bib0029","article-title":"Proprotein convertase subtilisin\/kexin type 9: a promising marker of cardiovascular risk in post-menopausal diabetic women in primary prevention","volume":"12","author":"Rottura","year":"2025","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"10.1016\/j.ajpc.2026.101785_bib0030","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.metabol.2015.01.009","article-title":"The effects of estrogen on serum level and hepatocyte expression of PCSK9","volume":"64","author":"Guo","year":"2015","journal-title":"Metab Clin Exp"},{"issue":"4","key":"10.1016\/j.ajpc.2026.101785_bib0031","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/eurheartj\/ehy357","article-title":"PCSK9 deficiency reduces insulin secretion and promotes glucose intolerance: the role of the low-density lipoprotein receptor","volume":"40","author":"Da Dalt","year":"2019","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.ajpc.2026.101785_bib0032","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ajpc.2026.101785_bib0033","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1161\/CIRCRESAHA.121.320056","article-title":"Proprotein convertase Subtilisin\/Kexin 9 (PCSK9) promotes macrophage activation via LDL receptor-independent mechanisms","volume":"131","author":"Katsuki","year":"2022","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101785_bib0034","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/CIRCULATIONAHA.120.051940","article-title":"PCSK9 (Proprotein Convertase Subtilisin\/Kexin 9) Goes \"DAMP\"","volume":"143","author":"Silverstein","year":"2021","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ajpc.2026.101785_bib0035","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaa073","article-title":"PCSK9 in African Americans and Caucasians in relation to lp(a) level, apo(a) size and heritability","volume":"4","author":"Enkhmaa","year":"2020","journal-title":"J Endocr Soc"},{"issue":"2","key":"10.1016\/j.ajpc.2026.101785_bib0036","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1194\/jlr.M055780","article-title":"Influence of physiological changes in endogenous estrogen on circulating PCSK9 and LDL cholesterol","volume":"56","author":"Ghosh","year":"2015","journal-title":"J Lipid Res"}],"container-title":["American Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667726003594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667726003594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:19:05Z","timestamp":1790036345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666667726003594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":36,"alternative-id":["S2666667726003594"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpc.2026.101785","relation":{},"ISSN":["2666-6677"],"issn-type":[{"value":"2666-6677","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating PCSK9 as a sex-stratified predictor in primary prevention of cardiovascular disease: Insights from a prospective cohort study in Chinese adults","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpc.2026.101785","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101785"}}